Capital Analysts LLC’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$369 Buy
+2
New +$435 ﹤0.01% 1627

Other funds holding AXSM

Capital Analysts LLC's AXSM Position: Q3 2026 in Review

Capital Analysts LLC opened a new position in Axsome Therapeutics (AXSM) in Q3 2026: 2 shares worth $369. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings.

462 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Capital Analysts LLC held 2 shares of Axsome Therapeutics worth $369 as of Q3 2026.
  • Axsome Therapeutics was a new Capital Analysts LLC position in Q3 2026.
  • Axsome Therapeutics made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1627 holding.
  • 462 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.